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Abstract
Background: Dab2, one of two mammalian orthologs of Drosophila Disabled, has been shown to
be involved in cell positioning and formation of visceral endoderm during mouse embryogenesis,
but its role in neuronal development is not yet fully understood. In this report, we have examined
the localization of the Dab2 protein in the mouse embryonic central nervous system (CNS) at
different developmental stages.
Results: Dab2 protein was transiently expressed in rhombomeres 5 and 6 of the developing
hindbrain between E8.5 and E11.5, and in the floor plate of the neural tube from E9.5 to E12.5,
following which it was no longer detectable within these regions. Dab2 protein was also identified
within circumventricular organs including the choroid plexus, subcommissural organ and pineal
gland during their early development. While Dab2 was still strongly expressed in the adult choroid
plexus, immunoreactivity within the subcommissural organ and pineal gland was lost after birth. In
addition, Dab2 was transiently expressed within a subpopulation of Iba1-positive mononuclear
phagocytes (including presumed microglial progenitors) within the neural tube from E10.0 and was
lost by E14.5. Dab2 was separately localized to Iba1 positive cells from E9.5 and subsequently to
F4/80 positive cells (mature macrophage/myeloid-derived dendritic cells) positioned outside the
neural tube from E12.5 onwards, implicating Dab2 expression in early cells of the mononuclear
phagocyte lineage. Dab2 did not co-localize with the pan-neuronal marker PGP9.5 at any
developmental stage, suggesting that Dab2 positive cells in the developing CNS are unlikely to be
differentiating neurons.
Conclusion: This is the first study to demonstrate the dynamic spatiotemporal expression of
Dab2 protein within the CNS during development.
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Dab2 was first identified as DOC-2 which is differentially
expressed in ovarian carcinoma and cell lines [1]. It was
later characterized as a tumor suppressor in various types
of tumors [2-7]. Subsequent studies indicated Dab2 as
one of two mammalian orthologs of the Drosophila Disa-
bled (dDab) [8-11], a family member of the Disabled pro-
teins involved in neurogenesis, oncogenesis, cellular
signaling and embryonic development. Three different
spliced forms of Dab2 cDNAs encoding variants p96, p93
and p67 were previously identified from a mouse macro-
phage library [12]. Of these, p96 was isolated as a
mitogenic responsive phosphoprotein with possible func-
tion in the macrophage CSF-1 signal transduction path-
way [12,13]. The complete genomic DNA sequence of the
mouse Dab2 gene and its chromosomal localization at
15A2 were reported [14].
Sequence analyses [1,11,14] indicated Dab2 as an adaptor
protein involved in signal transduction. The N-terminus
of the protein contains a highly conserved phosphotyro-
sine interacting domain (PID or PTB) which interacts with
proteins phosphorylated on tyrosine residue. Within its
C-terminus, the proline-rich domain exhibits multiple
SH3 binding motifs capable of interacting with SH3-con-
taining signaling molecules such as Grb2. Signaling path-
ways involving Dab2 have not been fully characterized.
However, there is evidence to suggest that Dab2 is an
essential component of the transforming growth factor β
(TGFβ) signaling pathway (involved in transmission of
TGFβ signaling from TGFβ receptors to the Smad family of
transcriptional activators) [15]. Dab2 has also been
shown to act as a regulator of the Ras/mitogen-activated
protein kinases (MAPK) pathway [16,17], Src activity [7]
and canonical Wnt/β-catenin-induced signaling [18].
Considering that molecular interactions through such sig-
naling pathways are important for normal growth and dif-
ferentiation of embryonic structures, it has been proposed
that Dab2 may also be involved in a number of different
developmental processes [19]. For example, expression of
Dab2 is upregulated upon retinoic acid treatment [20] or
during the normal differentiation of F9 cells, a multipo-
tent embryonic carcinoma cell line [21], into primitive
endoderm-like cells [22]. Cho et al. also showed that the
temporal expression pattern of the murine Dab2 gene
coincided with the initiation pattern of retinoic acid syn-
thesis in embryonic mice [20]. Furthermore, gene target-
ing studies have demonstrated that Dab2 is a direct and
specific downstream target of the zinc finger transcription
factor GATA-6 in the visceral endoderm [23]. In the
absence of Dab2, the visceral endoderm becomes disor-
ganized, resulting in growth failure of the inner cell mass.
The Dab2-deficient embryo then fails to gastrulate and
ceases development at around embryonic day 6.0 to 6.5
[19,23,24]. In addition to the visceral endoderm, Dab2
mRNA is also expressed in the branchial arch mesen-
chyme and septum transversum during development
[23]. A recent study showed that Dab2 is required for
TGFβ-induced epithelial-to-mesenchymal transition [25],
which is an important multi-step process necessary for the
proper development of many early embryonic structures
including the neural crest, the primitive streak and
somites [26-28].
Another mammalian ortholog of the Drosophila Disabled is
Dab1, a related gene which also contains PID in its N-ter-
minus. It has already been demonstrated that the Dab1
protein is important in regulating the positioning of
migrating neurons during mammalian neurogenesis [29-
31]. Mouse Dab1 is expressed in cortical neurons, and tar-
geted disruption of Dab1 resulted in abnormal neuronal
layering in the developing cerebral cortex and cerebellum,
together with an indistinct dentate gyrus and CA1 and
CA3 regions of the hippocampus [29]. Such defects partly
resulted from a failure of Dab1-/- neurons to detach from
radial glia during the late stage of neuronal migration
[30]. Despite the functional similarity of Dab1 and Dab2
proteins in cell positioning during development, it is not
known whether Dab2 also play key roles during the devel-
opment of the embryonic central nervous system (CNS),
although it has recently been shown that Dab2 inhibits
NGF-mediated neurite outgrowth in vitro [32]. Whether
the expression of Dab2 is regulated in a developmental
fashion has not been determined previously. Therefore in
this investigation our primary aim was to characterize the
spatiotemporal patterns of expression and the cellular
localization of Dab2 protein within the embryonic
murine CNS as an initial step towards further understand-
ing the developmental roles of Dab2.
Results
Dab2 immunoreactivity in the floor plate and 
rhombomeres
Dab2 immunoreactivity was first observed in the neu-
roepithelium of the prospective hindbrain region at E8.5
(8–10 somites stage) (Fig 1A, A'). The expression was
observed as a small positive band near the caudal margin
of the closing anterior neuropore, corresponding to the
position of rhombomeres 5 and 6 (Fig 1A, A'). This was
regionally restricted, as other regions of the neuroepithe-
lium lacked Dab2 expression. At E9.0 and E9.5, the neu-
roepithelium of rhombomere 6 was strongly Dab2
positive in its entire extent (Fig 1B, C, C', E, F), whereas
only the ventral part of rhombomere 5 showed immuno-
reactivity (Fig 1F, G, G"). In addition to rhombomeres 5
and 6, Dab2 was also expressed in a narrow strip of the
ventral neural tube extending from the mesencephalic
flexure down to the spinal neural tube (Fig 1B, F, G). Sec-
tions through the spinal neural tube revealed Dab2Page 2 of 11
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Dab2 immunoreactivity in the neural tubeFigure 1
Dab2 immunoreactivity in the neural tube. In whole mount preparations (A-D), tissues surrounding the neural tube, including the otic vesicle (aster-
isks in C) had been removed by microdissection. At E8.5, the neural tube (A: dorsal view; A': lateral view) already shows Dab2 expression in rhom-
bomeres 5 and 6 (arrowheads). At E9.0 (B: lateral view) and E9.5 (C: dorsal view; C': lateral view), expression within rhombomeres 5 and 6 (r5 and r6, 
arrows in C') remains strong, and spreads along the floor plate of the neural tube (arrowheads in B). The lack of immunoreactivity in the pre-adsorption 
control (D) confirms the specificity of the Dab2 immunoreaction. An oblique section (E) and longitudinal sections (F, G, G") through E9.5 embryos demon-
strate strong Dab2 expression in the whole span of r6 and weak immunoreactivity in the ventral part of r5 (G" shows the high magnification of the immu-
noreactive r5 and r6 in G). The pre-adsorption control section (G') adjacent to the section shown in G does not exhibit any immunoreactivity. The ventral 
expression of Dab2 in the floor plate of the neural tube extends rostrocaudally from the mesencephalic flexure (arrow, F) to the caudal spinal cord 
(arrow, G). At E10.5, Dab2 immunoreactivity becomes weak in r6 (arrow, H) (Hb; hindbrain; 4V: fourth ventricle) and absent in r5. Dab2 immunoreactiv-
ity along the floor plate of the spinal cord (arrowheads, I to M) is also observed in transverse sections through the rostral (I, J, K, L, M) and caudal spinal 
cord (I', J', K') at different developmental stage. Also note the weak Dab2 staining in the notochord (arrow, I'). Insets in I to M represent the high magnifi-
cation of the floor plate shown in corresponding figures. The schematic diagram (N) summarizes changes in Dab2 expression along the floor plate of the 
neural tube from E9.5 to E12.5. The dotted line indicates the axial level of the mesencephalic flexure and the shading represents Dab2 immunoreactivity 
observed in the floor plate of the neural tube. Arrowheads in N indicate regions of the neural tube from which sections shown in I, I', K, K', L, M were 
taken. Note that the onset and down-regulation of Dab2 expression follow a rostral-to-caudal sequence. Scale bar: 100 μm for I; 50 μm for G' and I', 25 
μm for insets of I-L, and 200 μm for other panels.
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expression in the floor plate was initially detected in the
rostral part of the spinal cord and gradually shifted in a
rostral-to-caudal manner to the caudal spinal cord (Fig
1N, compare Fig 1I with Fig 1I'). Weak Dab2 immunore-
activity was also detected in the caudal part of the noto-
chord (Fig 1I'). By E10.5, the Dab2 protein expression was
significantly down-regulated in these rhombomeres (Fig
1H) and became undetectable by E11.5. Likewise, Dab2
expression was progressively down-regulated in the floor
plate of the neural tube from E10.5 onwards. Down-regu-
lated expression of Dab2 in the floor plate, also occurred
in a rostral-to-caudal direction along the spinal cord (Fig
1N, also compare Fig 1I–K with Fig 1I'–K'). Dab2 immu-
noreactivity in the floor plate became undetectable by
E12.5 (Fig 1M). Negative controls did not show any
immunoreactive signals (Fig 1D, G').
Dab2 immunoreactivity in the developing choroid plexus
Dab2 protein was detected in the roof plate of the hind-
brain between E9.5 and E11.5 (Fig 2A, B, B', C, C'). At
E12.5, the developing choroid plexus of the lateral ventri-
cles and the fourth ventricle (Fig 2D, D') were Dab2
immunoreactive. The choroid plexus of the third ventri-
cle, which developed slightly later, was also positive for
Dab2 (data not shown). However, the neuroepithelium
adjacent to the choroid plexus was clearly negative and a
distinct boundary between the immunoreactive choroid
plexus and the adjacent neuroepithelium which lacked
staining, was easily discernible (Fig 2B–D). The entire
choroid plexus, including most of the epithelial cells that
lined the ventricles and their underlying mesenchyme,
was Dab2 positive (Fig 2D-F, 2D'). More intense expres-
sion was associated with the apical aspect (or luminal sur-
face, and associated microvilli) as compared to the basal
aspect of epithelial cells (Fig 2D'). The choroid plexus
continued to express the Dab2 protein in adulthood, and
consequently, became the most prominent Dab2 positive
structure in the adult CNS (Fig 2G), with the exception
that the intensity and localization of Dab2 expression was
reversed: in contrast to the embryonic choroid plexus,
which showed strong Dab2 immunoreactivity on the
luminal (apical) side of the epithelium (Fig 2D'), the
luminal surface of the epithelial cells in the adult choroid
plexus showed weaker immunoreactivity compared to the
basal surface (Fig 2G).
Dab2 immunoreactivity within the developing 
subcommissural organ and pineal gland
The presumptive subcommissural organ (SCO) develops
from the region of the roof plate of the diencephalon just
anterior to the mesencephalon (Fig 2H, H'). As develop-
ment progresses, the SCO neuroepithelium, which lies
underneath (ventral to) the posterior commissure,
became morphologically more distinct from the adjacent
neuroepithelium (Fig 2I–K). Dab2 immunoreactive cells
were detected in the developing SCO at E11.5 and the
expression became progressively more prominent (Fig
2H–K, 2H'–I'), particularly in the cell layers immediately
below the posterior commissure and also in the thin proc-
esses extending from the SCO to the posterior commis-
sure (Fig 2I', 2J–K). The ventricular aspect of the SCO
however showed only weak Dab2 immunoreactivity (Fig
2I', 2J–K). Double immunofluorescent labeling of Dab2
and PGP9.5, a pan-neuronal marker, was performed in
order to determine whether Dab2 was expressed in neu-
rons or nerve fibers that were closely associated with the
SCO. In embryos at late stages (E14.5–E16.5) the SCO
neuroepithelium was Dab2 positive but negative for
PGP9.5, whereas the posterior commissure above the
SCO was PGP9.5 positive but negative for Dab2 (Fig 2M–
M"), indicating that Dab2-immunoreactive cells were
unlikely to represent differentiating neurons. Dab2
expression was persistently detected in the SCO during
prenatal development but was not found in the adult (Fig
2L). The pineal gland additionally showed Dab2 immu-
noreactivity at E16.5 (Fig 2N) but Dab2 was not detecta-
ble in the adult pineal gland (data not shown).
Dab2 immunoreactivity in developing mononuclear 
phagocytes (fetal macrophages and microglial 
progenitors)
Within the developing neural tube
Scattered but strongly Dab2-immunoreactive cells were
detected within the neuroepithelium at E10.0 – E10.5 (Fig
3A). Double labeling with the Iba1 antibody (Fig 3A'), a
mononuclear phagocyte marker expressed on cells of the
macrophage and microglial cell lineages [33-35], showed
that the Dab2 protein was co-expressed with Iba1 protein
(Fig 3A"). Dab2 immunoreactive cells did not express
PGP9.5, indicating that they were not early differentiating
neurons (Fig 3B). Although all Dab2-positive cells
showed Iba1 immunoreactivity, cells that were Iba1 posi-
tive but Dab2 negative (Iba1+/Dab2-) were also observed
(Fig 3C). Iba1+/Dab2+ cells resembled the early fetal mac-
rophages previously reported in the developing CNS [35],
several of which were found in the proximity of blood ves-
sels at E10.5 (Fig 3D) and E11.5 (Fig 3E). However, their
close relationship with blood vessels was lost at E12.5, at
which time Iba1+/Dab2+ cells were found dispersed
throughout the neural tube (Fig 3F). Iba1+/Dab2+ fetal
macrophages were also frequently detected inside the ven-
tricles, in regions close to the ventricular wall (Fig 3G).
From E14.5 onwards, however, scattered Iba1+/Dab2+
cells were no longer detected within the neural tube, leav-
ing only Iba1+/Dab2- cells (presumed to represent paren-
chymal microglial progenitors) within the neural tube
(Fig 3H, H', H"). The endothelial lining of the brain
microvasculature also expressed Dab2 from E11.5
onwards (Fig 3E, F, I). In the adult, however, Dab2 immu-Page 4 of 11
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Dab2 immunoreactivity in the developing choroid plexus, subcommissural organ and pineal glandFigure 2
Dab2 immunoreactivity in the developing choroid plexus, subcommissural organ and pineal gland. Sections through the hindbrain (Hb) at 
stages from E9.5 to E11.5 (A to C; B' and C' represent the high magnification of the boxes in B and C, respectively) show Dab2 expression in the roof plate 
of the hindbrain (arrows) and on scattered round cells (mononuclear phagocytes). Note that the adjacent hindbrain neuroepithelium is negative for Dab2 
staining (arrowheads in B, C). Sections through the hindbrain (Hb) at stages from E12.5 to adulthood (D to G, D' is the higher magnification of the choroid 
plexus shown in D) show Dab2 staining in the choroid plexus (e.g. arrow in D) of the fourth ventricle (4V). Note the stronger Dab2 staining in the luminal 
(apical) surface of the epithelial cells as compared to the corresponding basal surface in embryos (arrowheads in D), but however, in the adult choroid 
plexus, the basal surface shows stronger Dab2 staining than the luminal (apical) surface of the epithelial cells (arrowheads in G). Also note the scattered 
and strongly Dab2 positive macrophages (arrows in D'). Sagittal sections show Dab2 staining in the subcommissural organ along the dorsal midline at dif-
ferent stages (H to K; H' and I' represent the higher magnification of the boxes in H and I, respectively). Note that Dab2 protein is expressed in the neu-
roepithelium of the subcommissural organ (sco) located in the roof plate of the diencephalon (Di). It lies underneath the posterior commissure (pc), 
anterior to the midbrain (Mb) (I', J, K). Also note the thin processes (arrows in I', J, K), which are also Dab2 positive, extending from the subcommissural 
organ into the posterior commissure. Coronal section (L) shows absence of Dab2 staining in the adult subcommissural organ. Double labeling of Dab2 
(green, M) with PGP9.5 (red, M') shows that they are not co-localized (M"). Arrowheads in M indicate autofluorescence in blood cells. The sagittal section 
(N) shows Dab2 staining in the developing pineal gland (pg) along the dorsal midline at E16.5. Fb: forebrain; Mb: midbrain; Hb: hindbrain. Di: diencephalon. 
4V: 4th ventricle; pc: posterior commissure; sco: subcommissural organ; pg: pineal gland. Scale bar: 50 μm.
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(also widely referred to as 'perivascular cells') associated
with cerebral blood vessels, but was absent from the
endothelial lining of these vessels (Fig 3J). Perivascular
cell expression of Dab2 was prominent throughout the
entire adult CNS. These cells were not uniform in shape
but were either oval with small processes, or flat and elon-
gated in shape (Fig 3J), as has been previously described
[36,37]. Unlike embryonic CNS, where cells closely
apposed to the microvasculature expressed both Iba1 and
Dab2 protein, Dab2 positive perivascular cells in the adult
brain did not appear to co-express Iba1 protein (Fig 3J–K).
Instead, double immunofluorescent labeling revealed
that some, but not all, of these Dab2 immunopositive
perivascular cells co-expressed F4/80 antigen, indicating
that they were of the macrophage lineage (mature macro-
phages) (Fig 3L, L', L").
Outside the developing neural tube
Scattered cells strongly positive for Dab2 were also
detected within mesenchymal tissues outside the neural
tube from E9.5 (Fig 3M), about half a day earlier than
Iba1+/Dab2+ cells inside the neural tube. These Dab2 pos-
itive cells were also Iba1 positive (Fig 3N, N', N"). The
macrophage differentiation marker, F4/80 antigen, began
to be expressed weakly in these fetal macrophages located
outside the neural tube at E12.5 and became prominent
from E14.5 onwards. Double immunofluorescence stain-
ing for Dab2 and F4/80 showed that all Dab2 positive
cells were also F4/80 immunoreactive from E14.5
onwards (Fig 3O, O', O"). In contrast to the transient,
developmentally-restricted expression of Dab2 protein
associated with mononuclear cells (microglial progeni-
tors) located inside the neural tube, Dab2 protein contin-
ued to be persistently expressed in macrophages
throughout the body into adulthood (data not shown).
Discussion
We have characterized in detail the expression pattern for
Dab2 in the mouse embryonic central nervous system
throughout development. Dynamic expression of Dab2
protein was detected in the neuroepithelium, blood ves-
sels, circumventricular organs and mononuclear phago-
cytes (fetal macrophages, microglial progenitors),
strongly suggesting that Dab2 is an important molecule
during mammalian CNS and myeloid cell development.
Unlike Dab1, which is expressed in cortical neurons,
Dab2 expression is restricted to non-neuronal cells or
immature neuroepithelial cells.
At E8.5, while signaling genes such as Hoxa1, Hoxa2,
Hoxb1, kr and Krox20 are interacting to pattern the early
hindbrain [38], Dab2 is expressed in presumptive rhom-
bomeres 5 and 6 (r5-6). There are 7 to 8 rhombomeres,
morphologically repeated compartments, transiently seg-
regated along the anteroposterior axis of the vertebrate
embryonic hindbrain. These compartments play pivotal
roles in the specification and segregation of neurons and
neural crest cells along the anteroposterior axis of the
hindbrain [39]. It is well-established that genes with
rhombomere-restricted expression (e.g. Hox genes) func-
tion to establish the identities of compartments [40].
Interestingly, it has been shown that Dab2 expression is
significantly up-regulated in Hoxa1 knockout embryonic
stem cells [41]. In the early hindbrain at E8.0 Hoxa1 is
expressed in r4-6 and gradually restricted to r4 at E8.5
[38]. Such down-regulation correlates spatiotemporally
with the onset of Dab2 expression within r5-6 at E8.5. A
further understanding of the interactions between Dab2
and Hoxa1 will greatly enhance our knowledge of signal-
ing cascades associated with hindbrain specification.
During development, dorsoventral patterning along the
neural tube is controlled by the expression of sonic hedge-
hog (shh) [42]. shh is expressed by cells along the ventral
midline of the embryonic forebrain, in the floor plate and
the notochord of the hindbrain and spinal cord [43].
Since the encoded protein is in a secreted form, Shh pro-
tein expression displays a more diffuse pattern [43]. Dab2
protein expression appears to overlap with the region
expressing shh mRNA in the floor plate and notochord at
E9.5 but not the regions showing Shh protein [43]. More-
over, Dab2 protein expression is turned off much earlier
in the floor plate (absent in E12.5) than for Shh in the
ventral spinal cord at E15.5 [43]. The potential involve-
ment of Dab2 in anteroposterior and dorsoventral pat-
terning requires further investigation.
Dab2 protein was also detected within circumventricular
organs including the choroid plexus, the subcommissural
organ and the pineal gland. Dab2 may represent one of
the earliest markers for the choroid plexus primordium in
the roof plate of the hindbrain. Its persistent expression in
the choroid plexus throughout life, however, indicates
that Dab2 may not only be involved in the early forma-
tion of the choroid plexus but may also have a role in the
transport of macromolecules across the epithelial cells of
the choroid plexus to the cerebral ventricles. Evidence to
support this hypothesis comes from studies on megalin, a
well-known receptor for Dab2 [44]. Megalin mediates the
transport of apolipoprotein J, Alzheimer's amyloid-beta
peptide, leptin, insulin-like growth factor-I, and also reg-
ulates macromolecule transport from the cerebral micro-
vessels and choroid plexus to cerebral ventricles, thereby
maintaining homeostasis in cerebrospinal fluid (CSF), as
well as exerting neuroprotective action [45-47]. In the
absence of Dab2, the protein levels of megalin are reduced
and the subcellular localization of megalin is altered [48].
The choroid plexus starts to secrete CSF very early during
development [49], correlating well with the early expres-Page 6 of 11
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tivity in mononuclear phagocytesFigure 3
Dab2 immunoreactivity in mononuclear phagocytes. A-A": Double labeling (immunofluorescence staining) on a sagittal section through an E10.5 
embryos shows co-localization of Dab2 (green, arrows in A) and Iba1 (red, arrows in A') in mononuclear phagocytes (yellow, arrows in A") within the neu-
ral tube (Ne, white outline), and in fetal macrophages outside the neural tube. B: Double labeling shows that Dab2 immunoreactivity (green, indicated by 
arrows) does not overlap with PGP9.5 immunoreactivity (red) within the neural tube (white outline) in a sagittal section through an E11.5 embryo. C: 
Double labeling at E12.5 shows Iba1+/Dab2- microglial progenitors (arrows, red) within the neural tube (Ne) and Iba1+/Dab2+ fetal macrophages (arrow-
head) in the adjacent mesenchyme (mes).D-F: Sagittal sections show that Dab2+ cells (arrows) are often closely apposed to blood vessels (arrowheads) 
within the neural tube at E10.5 (D) and E11.5 (E), but more scattered by E12.5 (F). G: Some Dab2+ cells (arrowheads) are also observed closely associated 
with the roof of the fourth ventricle (4V). H-H": Double labeling for Dab2 (green, H) and Iba1 (red, H') at E14.5 shows that Dab2 is only expressed in Iba1+ 
fetal macrophages (arrows) in the mesenchyme (mf: mesencephalic flexure, white outline) outside the neural tube (Ne) but absent in Iba1+ microglial pro-
genitors within the neural tube. I: At E16.5, Dab2 expression is detected in the wall of blood microvessels (arrowheads), but Dab2+ microglial progenitors 
are no longer detectable at this stage of development. J, K: Sections of an adult brain show Dab2+ perivascular cells (arrowheads in J) and Iba1+ microglia 
(arrows in K). L-L": A merged image (L") shows co-localization of F4/80 protein (red, L') in some (arrows in L") but not all of the Dab2+ (green, L) cells 
lying on the wall of cerebral microvessels (mv, white outline). M: A sagittal section of an E9.5 embryo shows Dab2+ cells in the cranial mensenchyme (mes) 
outside the neural tube (Ne). N-N": A merged image at E9.5 shows complete co-localization (yellow, brightfield, arrows in N") of Dab2 (green, arrows in 
N) and Iba1 (red, arrows in N') immunoreactivities in fetal macrophages outside the neural tube (Ne, white outline). O-O": A section through an E14.5 
choroid plexus shows complete co-localization (yellow, O") of Dab2 (green, O) and F4/80 (red, O') immunoreactivities. Arrowheads in O' and O" indicate 
autofluorescence from red blood cells. DAPI counterstained in B, C, H", L". Scale bar: 50 μm.
BMC Developmental Biology 2008, 8:76 http://www.biomedcentral.com/1471-213X/8/76sion of Dab2 protein. We found that Dab2 is also promi-
nently expressed in microvilli on the luminal surface of
the embryonic choroid epithelium, consistent with a role
associated with macromolecule transport and secretory
functions. However, the change observed in asymmetric
expression between the luminal and the basal surface
from embryonic to adult states (i.e. more prominent
expression in the basal compared to luminal aspect in the
adult) remains unclear.
Dab2 immunoreactivity was detected in another develop-
ing circumventricular organ, the subcommissural organ
(SCO). The SCO develops very early during embryogene-
sis, representing one of the first secretory brain structures
to differentiate [50]. The very early ontogenetic differenti-
ation of SCO secretory cells is crucial for the smooth cir-
culation of CSF secreted from the choroid plexus during
early development. The present study shows that Dab2 is
specifically expressed in the developing SCO primordium
at an early stage (E11.5). Both the choroid plexus and the
SCO are secretory organs that develop very early in
embryos. However, unlike the early and persistent expres-
sion of Dab2 in the choroid plexus, the Dab2 protein
appeared transiently in SCO-secretory cells, a phenome-
non that may possibly be related to the morphogenesis of
SCO. Similar to the SCO, the developing pineal gland also
showed transient Dab2 expression in the present study.
Dab2 expression in the developing pineal gland was not
detected at or before E14.5 but became distinct by E16.5,
the stage at which pinealocytes undergo rapid prolifera-
tion in rodents [51]. It is likely that Dab2 is expressed in
developing pinealocytes, although we cannot rule out the
possibility that interstitial cells also express the Dab2 pro-
tein. The functional significance of a transient expression
of Dab2 in the developing pineal gland remains to be
investigated.
Other than the expression in secretory epithelial cells,
Dab2 was also detected in cells of the myeloid lineage,
specifically mononuclear phagocytes. We have clearly
shown that Dab2 is expressed at early developmental
stages in mononuclear phagocytes (Iba1+/Dab2+ cells)
both outside the developing neural tube (from E9.5
onwards) and transiently within the neural tube (from
E10.5 – E14.5). The expression of Dab2 (or p96) in
mature macrophages is perhaps not surprising given its
initial characterization from a macrophage cell line [11-
13]. However, the functional roles played by Dab2 in lin-
eage commitment and differentiation of myeloid-derived
mononuclear phagocytes are only recently being investi-
gated [52], and have clear implications for determining
the lineage and differentiation also of microglia. ICSBP
(Interferon Consensus Sequence Binding Protein; a mem-
ber of the interferon regulatory factor family of transcrip-
tion factors which acts as a regulatory switch in myeloid
differentiation [52]), and the Ets transcription factor
PU.1, are haematopoietic-restricted transcription factors
critical for the development of haematopoietic cells [52].
PU.1 is an essential factor required for myeloid cell differ-
entiation [35]. Both of these transcription factors bind to
the Dab2 promoter, but whereas ICSBP represses Dab2
promoter transactivation, PU.1 induces it [52]. Signifi-
cantly, ICSBP represses the PU.1-induced transactivation,
thereby suppressing Dab2 expression. These data indicate
that cross-talk between PU.1 and ICSBP may be crucial in
regulating genes related to myeloid cell differentiation
and cell functions. Taken together and in context with our
current findings showing an increased and persistent
expression of Dab2 in developing and adult macrophages
compared to the lack of Dab2 in adult microglia, these
results allude to differences in myeloid cell differentiation
(and/or commitment) between macrophages and micro-
glial cells [35] that need to be explored in greater depth.
Transient expression of Dab2 was detected in early Iba-
1+cells located within the neural tube, in cells closely
apposed to blood vessels and to the ventricular walls.
These observations may imply that at least a subpopula-
tion of early microglia (Iba1+/Dab2+) are derived from
myeloid progenitors migrating into neural tube via micro-
vessels, rather than derived in situ [35]. Downregulation,
or indeed lack of Dab2 expression in subsequently devel-
oping microglia may represent an important event during
the differentiation and maturation of these cells.
Dab2 acts as a signalling molecule in CSF-1/MCSF (col-
ony stimulating factor-1/macrophage colony stimulating
factor) signal transduction [12,13]. Microglia, unlike cells
of the macrophage lineage, are not exclusively dependent
on CSF-1 for cell survival and differentiation [53-56]. The
lack of Dab2 protein expression in microglia (Iba1+/
Dab2-) which persists throughout development (E12.5-
14.5 onwards in this study), in adult CNS microglia at rest
(this study), and even under traumatic injury [57], may
reflect this lack of dependency on CSF-1/MCSF for differ-
entiation and/or survival of these cells, which in turn
points to differences in environmental trophic support for
mononuclear phagocytes within the CNS.
Although Dab2 was not expressed in adult microglia, it
was expressed in another mononuclear phagocytic cell
type in the CNS, namely perivascular macrophages which
co-expressed F4/80 antigen. The differential expression of
Dab2 in mononuclear phagocytes (microglia, fetal and
adult macrophages and perivascular macrophages)
renders it a useful marker to further study the origin and
responses of these cells.Page 8 of 11
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This is the first detailed report on the spatio-temporal
expression of Dab2 during CNS development in mam-
mals. Unlike Dab1, which is expressed in developing neu-
ronal cells, Dab2 protein is dynamically expressed in
various regions of the developing CNS, primarily
restricted to non-neuronal cells including within circum-
ventricular organs, in secretory cells, immature neuroepi-
thelial cells, endothelial cells and in populations of
mononuclear phagocytes (including fetal and perivascu-
lar macrophages), but lacking in neurons, neuroglial cells
and in mature microglia. These findings are consistent
with its expression pattern observed in the adult nervous
system (this study and [57]), and in response to CNS
injury [57] where Dab2 expression is primarily located to
macrophages accumulating at the site of injury, but absent
from neurons, neuroglia and microglia. Expression of
Dab2 in polarized epithelial cells in developing circum-
ventricular organs may be consistent with the well-docu-
mented functions of Dab2 in mediating endocytic
trafficking of clathrin-coated vesicles [58,59], and in
directing cell surface positioning [60]. Dab2 is further
implicated in myeloid cell differentiation and macro-
phage development. Our findings highlight the need for
further investigations into the biological functions of
Dab2 in early CNS and myeloid cell development.
Methods
Experimental animals
Random-bred ICR mice were kept at a constant tempera-
ture of 23 ± 2°C under a 12-hr light: 12-hr dark cycle at
the Laboratory Animal Services Centre of the Chinese
University of Hong Kong. They were provided with food
and water ad libitum. All experimental procedures involv-
ing the use of animals for experimental purposes were per-
formed under licence from the Government of the Hong
Kong SAR and endorsed by the Animal Experimentation
Ethics Committee of the Chinese University of Hong
Kong (Animal Ethics Approval Ref. No. 04/006/ERG).
Female mice weighing 35–40 g were paired with a male
mouse overnight. The noon of the plug day was desig-
nated as embryonic day 0.5 (E0.5) assuming that copula-
tion occurred around midnight.
Immunohistochemical staining and double 
immunofluorescence staining on tissue sections
Pregnant mice at different stages of pregnancy from E7.5
to E18.0 were sacrificed by cervical dislocation and uteri
dissected open. For each developmental stage, at least 5–
10 embryos were collected for analysis. Embryos were iso-
lated, fixed in Bouin's fixative, and processed for wax sec-
tioning. Sections of 7 μm thick were cut and mounted on
Superfrost® Plus microscopic slides (VWR Scientific).
Localization of the Dab2 protein by immunohistochemi-
cal staining was performed using the monoclonal anti-
p96/Dab2 antibody (1:400, Transduction Laboratories/
BD Biosciences). The peptide used to raise this mono-
clonal antibody corresponds to amino acids at positions
31–45 at the N-terminal of the full-length murine p96/
Dab2; a domain that is shared by the three known iso-
forms of Dab2 (namely p96, p93 and p67) in the mouse.
Antigen retrieval was carried out by microwave treatment
in 0.1 M citric acid buffer (pH 6.0). Immunostaining was
performed with the standard ABC method using DAB
(Sigma) as the chromogen [2,61]. Sections were counter-
stained with hematoxylin, dehydrated in a graded series of
alcohols, cleared in xylene and mounted in Permount
(Fisher Scientific). Images were taken under a Zeiss micro-
scope with a digital camera (Diagnostic instruments,
USA). The specificity of p96/Dab2 was confirmed by (1)
pre-adsorbing with the corresponding purified immuno-
gen (BD Biosciences) for 6 hr at 4°C before adding to the
sections, or (2) replacing the primary antibodies with PBS
containing 5% normal horse serum. For double immuno-
histochemical localization, 4% paraformaldehyde fixed
sections and antibodies to Dab2 (1:100, BD), Iba1 (1:75,
Wako), F4/80 (1: 50, Serotec), PGP 9.5 (1: 800, Ultra-
clone) were used. Secondary antibodies used were Alexa
Fluor-conjugated donkey antibodies against mouse, rab-
bit or rat (1:400, Invitrogen). Immunofluorescent images
were captured using a confocal microscope (Olympus
FluoView™-FV1000).
Whole mount immunohistochemistry
The procedure was carried out as previously described
[62]. Briefly, embryos were collected and fixed in Bouin's
fixative. They were dehydrated with upgraded methanol
and stored in pure methanol at -20°C until use. Embryos
were then treated with 2% Triton X-100 in DMSO/metha-
nol (4:1) overnight for permeabilization. They were
washed in 0.5% Triton X-100 in PBS (PBT) and treated
with 1% periodic acid overnight to block endogenous per-
oxidase activity. Non-specific binding was blocked with
5% non-fat dry milk in PBT (PBTM) before incubating the
embryos at 4°C overnight with the monoclonal anti-p96
antibody (1:400) [19,24]. Signals were amplified with the
standard ABC methods using DAB as chromogen. The
entire neural tube was isolated using tungsten needles and
brought to 80% glycerol in distilled water, through a
graded series, to obtain transparency. Images were cap-
tured with an AxioCam (Zeiss) under a stereomicroscope
(Zeiss).
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